ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing and marketing branded and generic prescription pharmaceuticals. It manufactures oral solid dose products, as well as liquids and topicals, including narcotics. Its other products include The Food and Drug Administration approved testosterone gel, which is licensed to Teva Pharmaceuticals USA. It performs contract manufacturing for other pharmaceutical companies. The Company has launched three products and has 11 products in development. Its targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities. In December 2013, the Company acquired 31 generic drug products from Teva Pharmaceuticals, which includes 20 solid-oral immediate release products, four extended release products and seven liquid products.